Prospective, multicentre, single-arm clinical trial of MISS score in the assessment of immune status in liver transplantation patients

Prospective clinical trial of immunostatus test (MISS score) in liver transplantation patients

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100044569

Enrollment

Unknown

Registered

2021-03-24

Start date

2021-03-25

Completion date

Unknown

Last updated

2021-09-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

End-stage liver disease, liver cancer, liver transplantation

Interventions

observation group:Nil

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Patients who have signed informed consent; 2. Adult allogeneic whole liver transplantation patients at each center; 3. Not participating in other clinical trials.

Exclusion criteria

Exclusion criteria: 1. Patients with poor dependence; 2. Liver transplantation patients with ultra-milan standard liver cancer; 3. Liver transplantation patients with autogenic immune liver disease.

Design outcomes

Primary

Measure	Time frame
MISS+MICA;	—

Secondary

Measure	Time frame
blood routine examination;Blood concentration of immunosuppressant drugs;Liver function, renal function, blood sugar and blood lipid;coagulation function;Hepatitis B, hepatitis C;procalcitonin;Infected pathogens and therapeutic antibiotics;	—

Countries

China

Contacts

Public ContactQiang He, Xianliang Li

Beijing Chaoyang Hospital, Capital Medical University

lixianliangbjcy@126.com+86 13521833013

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026